Oblimersen

From Wikipedia, the free encyclopedia

Oblimersen
Systematic (IUPAC) name
 ?
Identifiers
CAS number  ?
ATC code  ?
PubChem  ?
Chemical data
Formula  ?
Mol. mass  ?
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Oblimersen (INN; marketing name Genasense) is a proposed treatment for chronic lymphocytic leukemia.